Mode VC
California

Samsara BioCapital

Samsara BioCapital, based in California, backs life sciences startups at Seed, Series A, and Series B, leading rounds with checks from $10M to $30M.

Website LinkedInPortfolioPitch pageTeam page
Entry stageSeed, Series A, Series B
Check size$10M to $30M
Leads roundsYes
FocusLife sciences
Latest fundn/a
Investing team8 peopleNo activity since Sep

Who you would pitch at Samsara BioCapital

8 people on the investing team, 3 of them partners who can make the call. Partners are listed first.

Srini Akkaraju
Srini AkkarajuFounder & Managing PartnerHe previously held roles at several investment firms and companies, including Genentech and J.P.
Abe Bassan
Abe BassanPartnerHe previously held roles at Revolution Medicines, bluebird bio, and Third Rock Ventures, and founded Aurora Medical.
Mike Dybbs
Mike DybbsPartnerPreviously he was a Partner at New Leaf Venture Partners and a Principal at Boston Consulting Group.
Matt Eckler
Matt EcklerPrincipal, Public Investing
Mitchell Mutz
Mitchell MutzSenior PrincipalHe previously held roles at Vivo Capital and Roche Venture Fund, and co-founded Amplyx Pharmaceuticals.
Clara Dong
Clara DongSenior AssociateFocus: public biotech investments.
Ehi Akhirome
Ehi AkhiromeSenior AssociateFocus: biotech and diagnostics, with prior experience at Norwest and McKinsey.
Jake Bieber-Dishart
Jake Bieber-DishartSenior Associate

Work here and something is wrong? Ask for a correction.

Writes $10M to $30M checks. Its smallest check is larger than 97% of firms in the atlas.

Bars: how many firms in the atlas report each band. Highlighted: this firm.

No recent activity since September 2026. Quiet does not mean closed.

Weekly count of activity updates. Activity is not a confirmed deal.

Before you pitch

Ownership target5-7%
How to reach them[email protected]

Notable investments

ArcellxPrime MedicineSutro BiopharmaScholar RockNkartaDICE TherapeuticsHillevaxNeurogene

In their words

SAMSARA BIOCAPITALFounder’s Corner Investing to create transformative therapeutics for patients. The Tree of Life Darwin’s Tree of Life (1837) Darwin’s Origin of Species is the foundation www.samsaracap.com
Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Alert me when Samsara BioCapital is active

One email when this firm shows new activity. Nothing else.

Firms like Samsara BioCapital

DCVC$10M to $30M+ · active Oct 8
Sofinnova Investments$10M to $30M
Telegraph Hill Partners$10M to $30M
HealthQuest Capital$10M to $30M+
TCG Crossover$10M to $30M+
Hitachi Ventures$1M to $30M · active Oct 15

On these lists

Seed life sciences investors in California71Series A life sciences investors in California65Series B life sciences investors in California30Seed investors in United States2836Series A investors in United States1790Seed investors in California699Series B investors in United States563Series A investors in California480

Questions

What stage does Samsara BioCapital invest in?

Samsara BioCapital reports entry at seed, series a, series b.

How much does Samsara BioCapital invest?

Samsara BioCapital reports checks of $10M to $30M.

Does Samsara BioCapital lead rounds?

Yes. Samsara BioCapital says it can lead.

Who are the partners at Samsara BioCapital?

Srini Akkaraju (Founder & Managing Partner), Abe Bassan (Partner), Mike Dybbs (Partner).

Is Samsara BioCapital active right now?

No recent activity since September 2026.

Work at Samsara BioCapital? Claim or correct this profile.